Financhill
Buy
56

CGNX Quote, Financials, Valuation and Earnings

Last price:
$31.23
Seasonality move :
7.62%
Day range:
$31.73 - $32.50
52-week range:
$30.04 - $53.13
Dividend yield:
0.96%
P/E ratio:
53.02x
P/S ratio:
6.10x
P/B ratio:
3.62x
Volume:
1.8M
Avg. volume:
2M
1-year change:
-19.37%
Market cap:
$5.5B
Revenue:
$914.5M
EPS (TTM):
$0.61

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CGNX
Cognex
$220.7M $0.16 1.66% 89.33% $42.57
FCUV
Focus Universal
-- -- -- -- --
KEYS
Keysight Technologies
$1.3B $1.69 5.44% 128.71% $184.86
MLAB
Mesa Laboratories
$58.8M $1.51 4.46% 287.18% $150.00
QRVO
Qorvo
$910.8M $1.21 -9.64% 3408.34% $91.12
SOTK
Sono-Tek
$5.1M $0.01 7.48% -- $8.25
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CGNX
Cognex
$32.34 $42.57 $5.5B 53.02x $0.08 0.96% 6.10x
FCUV
Focus Universal
$4.69 -- $33.4M -- $0.00 0% 70.55x
KEYS
Keysight Technologies
$152.73 $184.86 $26.4B 43.76x $0.00 0% 5.32x
MLAB
Mesa Laboratories
$126.12 $150.00 $685.3M -- $0.16 0.51% 2.88x
QRVO
Qorvo
$72.02 $91.12 $6.7B 254.63x $0.00 0% 1.82x
SOTK
Sono-Tek
$3.63 $8.25 $57.2M 51.86x $0.00 0% 2.84x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CGNX
Cognex
-- 1.466 -- 2.32x
FCUV
Focus Universal
-- 1.694 -- 4.13x
KEYS
Keysight Technologies
25.66% 1.630 5.8% 1.99x
MLAB
Mesa Laboratories
55.77% -0.320 27.31% 0.45x
QRVO
Qorvo
31.43% 0.753 23.68% 1.50x
SOTK
Sono-Tek
-- 1.170 -- 2.26x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CGNX
Cognex
$157.9M $30.8M 7% 7% 13.43% $49.3M
FCUV
Focus Universal
-$127.1K -$2M -77.46% -101.87% -1472.35% -$1M
KEYS
Keysight Technologies
$820M $218M 8.93% 12.1% 16.87% $346M
MLAB
Mesa Laboratories
$39.8M $5.8M -59.87% -122.79% 1% $17.6M
QRVO
Qorvo
$391.4M $53M 0.5% 0.77% 7.37% $176.2M
SOTK
Sono-Tek
$2.3M $197.6K 6.6% 6.6% 3.81% $1.1M

Cognex vs. Competitors

  • Which has Higher Returns CGNX or FCUV?

    Focus Universal has a net margin of 12.34% compared to Cognex's net margin of -1472.68%. Cognex's return on equity of 7% beat Focus Universal's return on equity of -101.87%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex
    68.73% $0.16 $1.5B
    FCUV
    Focus Universal
    -95.41% -$0.28 $3.2M
  • What do Analysts Say About CGNX or FCUV?

    Cognex has a consensus price target of $42.57, signalling upside risk potential of 31.62%. On the other hand Focus Universal has an analysts' consensus of -- which suggests that it could fall by --. Given that Cognex has higher upside potential than Focus Universal, analysts believe Cognex is more attractive than Focus Universal.

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex
    8 11 0
    FCUV
    Focus Universal
    0 0 0
  • Is CGNX or FCUV More Risky?

    Cognex has a beta of 1.428, which suggesting that the stock is 42.75% more volatile than S&P 500. In comparison Focus Universal has a beta of 0.268, suggesting its less volatile than the S&P 500 by 73.184%.

  • Which is a Better Dividend Stock CGNX or FCUV?

    Cognex has a quarterly dividend of $0.08 per share corresponding to a yield of 0.96%. Focus Universal offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cognex pays 49.29% of its earnings as a dividend. Focus Universal pays out -- of its earnings as a dividend. Cognex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or FCUV?

    Cognex quarterly revenues are $229.7M, which are larger than Focus Universal quarterly revenues of $133.2K. Cognex's net income of $28.3M is higher than Focus Universal's net income of -$2M. Notably, Cognex's price-to-earnings ratio is 53.02x while Focus Universal's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex is 6.10x versus 70.55x for Focus Universal. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex
    6.10x 53.02x $229.7M $28.3M
    FCUV
    Focus Universal
    70.55x -- $133.2K -$2M
  • Which has Higher Returns CGNX or KEYS?

    Keysight Technologies has a net margin of 12.34% compared to Cognex's net margin of 13.02%. Cognex's return on equity of 7% beat Keysight Technologies's return on equity of 12.1%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex
    68.73% $0.16 $1.5B
    KEYS
    Keysight Technologies
    63.17% $0.97 $7B
  • What do Analysts Say About CGNX or KEYS?

    Cognex has a consensus price target of $42.57, signalling upside risk potential of 31.62%. On the other hand Keysight Technologies has an analysts' consensus of $184.86 which suggests that it could grow by 21.03%. Given that Cognex has higher upside potential than Keysight Technologies, analysts believe Cognex is more attractive than Keysight Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex
    8 11 0
    KEYS
    Keysight Technologies
    6 1 0
  • Is CGNX or KEYS More Risky?

    Cognex has a beta of 1.428, which suggesting that the stock is 42.75% more volatile than S&P 500. In comparison Keysight Technologies has a beta of 1.097, suggesting its more volatile than the S&P 500 by 9.732%.

  • Which is a Better Dividend Stock CGNX or KEYS?

    Cognex has a quarterly dividend of $0.08 per share corresponding to a yield of 0.96%. Keysight Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cognex pays 49.29% of its earnings as a dividend. Keysight Technologies pays out -- of its earnings as a dividend. Cognex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or KEYS?

    Cognex quarterly revenues are $229.7M, which are smaller than Keysight Technologies quarterly revenues of $1.3B. Cognex's net income of $28.3M is lower than Keysight Technologies's net income of $169M. Notably, Cognex's price-to-earnings ratio is 53.02x while Keysight Technologies's PE ratio is 43.76x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex is 6.10x versus 5.32x for Keysight Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex
    6.10x 53.02x $229.7M $28.3M
    KEYS
    Keysight Technologies
    5.32x 43.76x $1.3B $169M
  • Which has Higher Returns CGNX or MLAB?

    Mesa Laboratories has a net margin of 12.34% compared to Cognex's net margin of -2.67%. Cognex's return on equity of 7% beat Mesa Laboratories's return on equity of -122.79%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex
    68.73% $0.16 $1.5B
    MLAB
    Mesa Laboratories
    63.26% -$0.31 $350.9M
  • What do Analysts Say About CGNX or MLAB?

    Cognex has a consensus price target of $42.57, signalling upside risk potential of 31.62%. On the other hand Mesa Laboratories has an analysts' consensus of $150.00 which suggests that it could grow by 18.93%. Given that Cognex has higher upside potential than Mesa Laboratories, analysts believe Cognex is more attractive than Mesa Laboratories.

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex
    8 11 0
    MLAB
    Mesa Laboratories
    2 1 1
  • Is CGNX or MLAB More Risky?

    Cognex has a beta of 1.428, which suggesting that the stock is 42.75% more volatile than S&P 500. In comparison Mesa Laboratories has a beta of 0.818, suggesting its less volatile than the S&P 500 by 18.174%.

  • Which is a Better Dividend Stock CGNX or MLAB?

    Cognex has a quarterly dividend of $0.08 per share corresponding to a yield of 0.96%. Mesa Laboratories offers a yield of 0.51% to investors and pays a quarterly dividend of $0.16 per share. Cognex pays 49.29% of its earnings as a dividend. Mesa Laboratories pays out -1.36% of its earnings as a dividend. Cognex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or MLAB?

    Cognex quarterly revenues are $229.7M, which are larger than Mesa Laboratories quarterly revenues of $62.8M. Cognex's net income of $28.3M is higher than Mesa Laboratories's net income of -$1.7M. Notably, Cognex's price-to-earnings ratio is 53.02x while Mesa Laboratories's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex is 6.10x versus 2.88x for Mesa Laboratories. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex
    6.10x 53.02x $229.7M $28.3M
    MLAB
    Mesa Laboratories
    2.88x -- $62.8M -$1.7M
  • Which has Higher Returns CGNX or QRVO?

    Qorvo has a net margin of 12.34% compared to Cognex's net margin of 4.5%. Cognex's return on equity of 7% beat Qorvo's return on equity of 0.77%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex
    68.73% $0.16 $1.5B
    QRVO
    Qorvo
    42.72% $0.43 $4.9B
  • What do Analysts Say About CGNX or QRVO?

    Cognex has a consensus price target of $42.57, signalling upside risk potential of 31.62%. On the other hand Qorvo has an analysts' consensus of $91.12 which suggests that it could grow by 26.52%. Given that Cognex has higher upside potential than Qorvo, analysts believe Cognex is more attractive than Qorvo.

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex
    8 11 0
    QRVO
    Qorvo
    3 17 1
  • Is CGNX or QRVO More Risky?

    Cognex has a beta of 1.428, which suggesting that the stock is 42.75% more volatile than S&P 500. In comparison Qorvo has a beta of 1.476, suggesting its more volatile than the S&P 500 by 47.557%.

  • Which is a Better Dividend Stock CGNX or QRVO?

    Cognex has a quarterly dividend of $0.08 per share corresponding to a yield of 0.96%. Qorvo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cognex pays 49.29% of its earnings as a dividend. Qorvo pays out -- of its earnings as a dividend. Cognex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or QRVO?

    Cognex quarterly revenues are $229.7M, which are smaller than Qorvo quarterly revenues of $916.3M. Cognex's net income of $28.3M is lower than Qorvo's net income of $41.3M. Notably, Cognex's price-to-earnings ratio is 53.02x while Qorvo's PE ratio is 254.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex is 6.10x versus 1.82x for Qorvo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex
    6.10x 53.02x $229.7M $28.3M
    QRVO
    Qorvo
    1.82x 254.63x $916.3M $41.3M
  • Which has Higher Returns CGNX or SOTK?

    Sono-Tek has a net margin of 12.34% compared to Cognex's net margin of 5.28%. Cognex's return on equity of 7% beat Sono-Tek's return on equity of 6.6%.

    Company Gross Margin Earnings Per Share Invested Capital
    CGNX
    Cognex
    68.73% $0.16 $1.5B
    SOTK
    Sono-Tek
    45.14% $0.02 $17.4M
  • What do Analysts Say About CGNX or SOTK?

    Cognex has a consensus price target of $42.57, signalling upside risk potential of 31.62%. On the other hand Sono-Tek has an analysts' consensus of $8.25 which suggests that it could grow by 127.27%. Given that Sono-Tek has higher upside potential than Cognex, analysts believe Sono-Tek is more attractive than Cognex.

    Company Buy Ratings Hold Ratings Sell Ratings
    CGNX
    Cognex
    8 11 0
    SOTK
    Sono-Tek
    2 0 0
  • Is CGNX or SOTK More Risky?

    Cognex has a beta of 1.428, which suggesting that the stock is 42.75% more volatile than S&P 500. In comparison Sono-Tek has a beta of -0.239, suggesting its less volatile than the S&P 500 by 123.856%.

  • Which is a Better Dividend Stock CGNX or SOTK?

    Cognex has a quarterly dividend of $0.08 per share corresponding to a yield of 0.96%. Sono-Tek offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cognex pays 49.29% of its earnings as a dividend. Sono-Tek pays out -- of its earnings as a dividend. Cognex's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios CGNX or SOTK?

    Cognex quarterly revenues are $229.7M, which are larger than Sono-Tek quarterly revenues of $5.2M. Cognex's net income of $28.3M is higher than Sono-Tek's net income of $274.2K. Notably, Cognex's price-to-earnings ratio is 53.02x while Sono-Tek's PE ratio is 51.86x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cognex is 6.10x versus 2.84x for Sono-Tek. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CGNX
    Cognex
    6.10x 53.02x $229.7M $28.3M
    SOTK
    Sono-Tek
    2.84x 51.86x $5.2M $274.2K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Alphabet Stock No Longer a Good Bet?
Is Alphabet Stock No Longer a Good Bet?

Alphabet tripled its price per share over the past 5…

Pepsi Vs Coke Stock: Which Is Best?
Pepsi Vs Coke Stock: Which Is Best?

Coca-Cola (NYSE:KO) and PepsiCo (NYSE:PEP) are two of the largest…

Is CyberArk The Next Big Cybersecurity Stock?
Is CyberArk The Next Big Cybersecurity Stock?

CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Sell
48
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 39x

Alerts

Buy
52
RGC alert for Mar 19

Regencell Bioscience Holdings [RGC] is down 0.66% over the past day.

Sell
49
SRPT alert for Mar 19

Sarepta Therapeutics [SRPT] is up 8.72% over the past day.

Sell
46
CVNA alert for Mar 19

Carvana [CVNA] is up 5.74% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock